TMEM87a is a ferroptosis suppressor mediating cancer immunotherapy resistance (PRJCA039255)
To examine whether tumoral TMEM87a loss reshaped the tumor immune microenvironment (TIME), we performed the single-cell RNA sequencing (scRNA-seq) analysis on CD45+ cells enriched from B16F10 KO-Vector and KO-TMEM87a-Flag tumors.